Journal News

Exercise and fatty food: Using plasma proteomics to understand obesity

Kian Kamgar-Parsi
July 15, 2021

During the COVID-19 pandemic, one of Western society’s greatest health problems has continued its decades-long rise: obesity. According to the Centers for Disease Control and Prevention, obesity rates nearly tripled from 1962 to 2016 (from 14% to 40%), with obesity-related health care costs now likely over $150 billion annually. While the effects of obesity are easy to see, our understanding of its underlying physiology continues to evolve.

Fat-mouse-445x250.jpg
Bigplankton/Wikimedia Commons
A high-fat diet is known to cause obesity in both mice and humans. New research
highlighting how exercise can prevent high fat diet–induced changes in protein
levels could provide new tools in the fight against obesity.

“Unfortunately, obesity is at epidemic levels in our communities,” Stephen Twigg, an endocrinologist at the University of Sydney, said. “Methods to prevent it, let alone treat it, are still quite lacking.”

Twigg and University of Sydney biochemist Mark Larance, along with an international team of scientists, have sought to characterize the interplay of two key obesity triggers. High-fat diets, or HFD, and lack of exercise both have been implicated in obesity; however, their effect on the plasma proteome (the milieu of soluble proteins within an organism) has not been well characterized. In a paper recently published in the journal Molecular & Cellular Proteomics, Larance and Twigg compared mice fed an HFD to those fed a normal diet and subjected to various exercise regimens to elucidate their combined effect on the plasma proteome.

Following 10 weeks on an HFD, nearly 40% of detected plasma proteins in the mice showed changes. These changes were primarily in liver-associated proteins such as aldolase B, or ALDOB (a key sugar-metabolizing enzyme), a finding consistent with the prevalence of liver damage in obese mice and humans. For mice where these changes already had occurred, exercise as treatment after the fact provided little benefit: Only two of the 82 changed proteins were returned to pre-HFD levels. However, in mice that exercised concurrently with the HFD, roughly 20% of the proteins that were altered in the nonexercising mice maintained their healthy baselines. These effects were independent of the type of exercise, with both endurance and high-intensity interval exercise showing similar results.

“This is one of the first unbiased analyses of the response to HFD,” Larance said. “A lot of those changes, we couldn’t have predicted what they would be. I’ve got the feeling that there are definitely proteins in the plasma that are being ignored at the moment that could be more sensitive than some of the current markers of liver damage … For example, ALDOB might be a more sensitive measure (than current clinical markers) both in humans and in mice.”

Despite these exciting discoveries, significant questions remain. “From the most abundant protein to the least abundant protein spans 13 orders of magnitude,” Larance said, noting the difficulty in detecting low-concentration but important protein species. The type of HFD also heavily influences outcomes, with proteins behaving differently based on the types of fats and number of calories eaten. Additionally, as with any study in mice, differences between the specific changes seen in them and in humans are likely.

Despite these limitations, Larance and Twigg’s work provides a significant advance in our understanding of the proteomics of obesity, and if nothing else, as Twigg concluded, “Probably much better to do some exercise rather than none.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Kian Kamgar-Parsi

Kian Kamgar-Parsi received a Ph.D. in biophysics from the University of Michigan and works as a consultant for the pharmaceutical industry.
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The molecular biology behind exercise
Journal News

The molecular biology behind exercise

Oct. 1, 2024

Researchers in Beijing use proteomic analysis to understand the muscular adaptations made during concentric and eccentric movements.

A common parasite could one day deliver drugs to the brain
News

A common parasite could one day deliver drugs to the brain

Sept. 29, 2024

Bill Sullivan explains how scientists are turning Toxoplasma gondii, often found in contaminated food or cat feces, from foe into friend.

Not so selfish after all: Viruses use freeloading genes as weapons
News

Not so selfish after all: Viruses use freeloading genes as weapons

Sept. 28, 2024

Phage viruses, increasingly used to treat antibiotic resistance, gain an advantage by cutting off a competitor’s ability to reproduce.

From the Journals: JBC
Journal News

From the Journals: JBC

Sept. 27, 2024

An Alzheimer’s disease neuronal traffic jam. Mutant Rab35 linked to neurodevelopment disorder. Is ORMDL3 a new drug target for ulcerative colitis? Read about recent JBC papers on these topics.

Yellow food dye can make living tissue transparent
News

Yellow food dye can make living tissue transparent

Sept. 22, 2024

These new methods could one day improve cancer treatment, blood draws and even tattoo removal.

Scientists discover brain circuits for placebo effect pain relief
News

Scientists discover brain circuits for placebo effect pain relief

Sept. 21, 2024

A new pain control pathway from the cortex to the cerebellum is crucial when the expectation of relief leads to pain alleviation without a therapeutic intervention.